Properties This code system defines the following properties for its concepts Name Code URI Type Description Specializes Specializes Coding The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric. Generalizes Generalizes Coding Inverse of Specializes. Only included as a derived relationship. internalId internalId http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id code The internal identifier for the concept in the HL7 Access database repository. Not Selectable notSelectable http://hl7.org/fhir/concept-properties#notSelectable boolean Indicates that the code is abstract - only intended to be used as a selector for other concepts status status http://hl7.org/fhir/concept-properties#status code Designation of a concept's state. Normally is not populated unless the state is retired. Concepts This case-sensitive code system http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution defines the following codes in a Is-A hierarchy: Lvl Code Display Definition internalId Not Selectable status 1 _ActSubstanceAdminSubstitutionCode ActSubstanceAdminSubstitutionCode Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects. 21284 true active 2 E equivalent Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product. 23107 active 3 EC equivalent composition Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril 23108 active 4 BC brand composition Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven 23109 active 4 G generic composition Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp) 16623 active 3 TE therapeutic alternative Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet 16624 active 4 TB therapeutic brand Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics Examples: Zantac for Tagamet 23105 active 4 TG therapeutic generic Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands Examples: Ranitidine for cimetidine 23106 active 2 F formulary Description: This substitution was performed or is permitted based on formulary guidelines. 16625 active 2 N none No substitution occurred or is permitted. 16622 active
Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.
This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license
The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.
Inverse of Specializes. Only included as a derived relationship.
The internal identifier for the concept in the HL7 Access database repository.
Indicates that the code is abstract - only intended to be used as a selector for other concepts
Designation of a concept's state. Normally is not populated unless the state is retired.
**Description:** Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.
**Description:** Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
**Description:** Substitution occurred or is permitted with another product that is a: * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration *Examples:* * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate * *Pharmaceutical equivalent:* Lisonpril for Zestril
**Description:** Substitution occurred or is permitted between equivalent Brands but not Generics *Examples:* * Zestril for Prinivil * Coumadin for Jantoven
**Description:** Substitution occurred or is permitted between equivalent Generics but not Brands *Examples:* * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
**Description:** Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. *Examples:* * ranitidine for Tagamet
**Description:** Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > *Examples:* * Zantac for Tagamet
**Description:** Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > *Examples:* * Ranitidine for cimetidine
**Description:** This substitution was performed or is permitted based on formulary guidelines.
No substitution occurred or is permitted.